Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ABALOPARATIDE vs ABROCITINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ABALOPARATIDE vs ABROCITINIB: Safety Overview

Metric ABALOPARATIDE ABROCITINIB
Total FAERS Reports 23,362 3,170
Deaths Reported 219 57
Death Rate 0.9% 1.8%
Hospitalizations 1,400 329
Average Patient Age 67.3 yrs 48.5 yrs
% Female Patients 95.2% 53.9%
FDA Approval Date Apr 28, 2017 Jan 14, 2022
Manufacturer Radius Health, Inc. U.S. Pharmaceuticals
Route SUBCUTANEOUS ORAL
Marketing Status Prescription Prescription